Antimicrobial Resistance in Typhoidal Salmonella in a Tertiary Care Teaching Centre in North India
Ceftriaxone Resistant Typhoidal Salmonella
Abstract
Introduction: Enteric fever continues to carry a high burden of morbidity and mortality in India. There have been reports of emergence of ceftriaxone resistant typhoidal Salmonella from Asia. Monitoring of antimicrobial resistance trends in typhoidal Salmonella is crucial to support in clinical decision making.
Aim: To study the current susceptibility pattern of typhoidal salmonella isolates in our setup.
Methods: This retrospective study was conducted on 144 non-repeat blood-culture isolates of S. Typhi, and S. Paratyphi A obtained from 3926 blood cultures received at 510-bedded tertiary-care hospital of North-India from 2017-2019. Identification and antibiograms were obtained by Vitek-2 compact and Kirby-Bauer’s disc diffusion with sensitivity to azithromycin, and chloramphenicol.
Result: S. Typhi and S. Paratyphi A in a ratio of 5.2:1 were seen between months of June and July predominantly distributed between 1-10 years age group. S. Typhi resistance to co-trimoxazole, chloramphenicol, ceftriaxone and azithromycin was 21.4%, 25.6%, 12.3% and 28% respectively. S. Paratyphi A resistance to co-trimoxazole, chloramphenicol, ceftriaxone and azithromycin was 4.3%, 17.3%, 34.7% and 21.7% respectively.
Conclusion: Enteric-fever is a major public-health problem in India. Emergence of ceftriaxone-resistant Salmonella mandates appropriate investigation of all febrile illnesses with blood culture whenever possible. Provision of safe drinking water, good sanitation, hygiene and vaccination strategies are needed to sustain herd-immunity.
How to cite this article:
Taneja J, Khatter S, Paul M, Pandey A, Kaur I. Antimicrobial Resistance in Typhoidal Salmonella in a Tertiary Care Teaching Centre in North India. J Commun Dis 2021; 53(1): 1-4.
DOI: https://doi.org/10.24321/0019.5138.202101
References
Mogasale V, Maskery B, Ochiai RL et al. Burden of typhoid fever in low-income and middle-income
countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health 2014; 2(10):
e570-80.
National Treatment Guidelines for Antimicrobial Use in Infectious Diseases 2016. National Centre for Disease
Control, Directorate General of Health Services Ministry of Health & Family Welfare Government of India.
Crump JA, Sjölund-Karlsson M, Gordon MA et al. Epidemiology, clinical presentation, laboratory
diagnosis, antimicrobial resistance, and antimicrobial management of invasive salmonella infections. Clin
Microbiol Rev 2015; 28(4): 901-937.
Clinical and Laboratory Standards Institute. M100. Performance Standard for Antimicrobial Susceptibility
Testing: Thirtieth Informational Supplement. Clinical and Laboratory Standard Institute, Wayne, PA. 2020.
Harichandran D, Dinesh KR. Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India. Infect Drug Resist 2017; 10: 97-101.
Singhal L, Gupta PK, Kale P et al. Trends in antimicrobial susceptibility of Salmonella Typhi from North India
(2001-2012). Indian J Med Microbiol 2014; 32(2): 149-52.
Bhattacharya SS, Das U, Choudhury BK. Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A
isolated from Rourkela, Orissa. Indian J Med Res 2011; 133(4): 431-433.
Makkar A, Gupta S, Khan ID et al. Epidemiological profile and antimicrobial resistance pattern of entericfever in a tertiary care hospital of North India - a Seven Year Ambispective Study. Acta Medica (Hradec Kralove)
; 61(4): 125-130.
Wattal C, Goel N. Pediatric blood cultures and antibiotic resistance: an overview. Indian J Pediatr 2020; 87(2):
-131.
Sharma P, Dahiya S, Manral N et al. Changing trends of culture-positive typhoid fever and antimicrobial
susceptibility in a tertiary care North Indian Hospital over the last decade. Indian J Med Microbiol 2018;
(1): 70-76.
Patel SR, Bharti S, Pratap CB et al. Drug resistance pattern in the recent isolates of salmonella typhi with
special reference to cephalosporins and azithromycin in the gangetic plain. J Clin Diagn Res 2017; 11(6): DM01-3.
Dutta S, Das S, Mitra U et al. Antimicrobial resistance, virulence profiles and molecular subtypes of Salmonella
enterica serovars Typhi and Paratyphi A blood isolates from Kolkata, India during 2009-2013. PLoS One 2014;
(8): e101347.
Patil N, Mule P. Sensitivity pattern of salmonella typhi and paratyphi an isolates to chloramphenicol
and other anti-typhoid drugs: an in vitro study. Infect Drug Resist 2019; 12: 3217-25.
Britto CD, John J, Verghese VP et al. A systematic review of antimicrobial resistance of typhoidal Salmonella in
India. Indian J Med Res 2019; 149(2): 151-163.
Copyright (c) 2021 Journal of Communicable Diseases (E-ISSN: 2581-351X & P-ISSN: 0019-5138)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
